ACRVVSMRNA• 28 Days (Normalized)
ACRV vs MRNA (Acrivon Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
-28.87%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $145.62
-16.49%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-12.38%
MRNA outperforming by 12.38%
ACRVMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ACRV Price | ACRV Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | -28.87% | $145.62 | -16.49% | -12.38% |
| Sep 15, 2026 | $1.83 | -23.43% | $143.77 | -17.55% | -5.88% |
| Sep 14, 2026 | $1.96 | -17.99% | $146.69 | -15.88% | -2.11% |
| Sep 11, 2026 | $2.00 | -16.32% | $143.97 | -17.44% | +1.12% |
| Sep 10, 2026 | $2.04 | -14.64% | $136.62 | -21.65% | +7.01% |
| Sep 09, 2026 | $1.99 | -16.74% | $135.61 | -22.23% | +5.49% |
| Sep 08, 2026 | $2.10 | -12.13% | $140.33 | -19.53% | +7.40% |
| Sep 04, 2026 | $2.13 | -10.88% | $145.55 | -16.53% | +5.65% |
| Sep 03, 2026 | $2.06 | -13.81% | $148.87 | -14.63% | +0.82% |
| Sep 02, 2026 | $2.15 | -10.04% | $150.81 | -13.52% | +3.48% |
| Sep 01, 2026 | $2.07 | -13.39% | $154.27 | -11.53% | -1.86% |
| Aug 31, 2026 | $2.09 | -12.55% | $140.34 | -19.52% | +6.97% |
| Aug 28, 2026 | $2.06 | -13.81% | $137.99 | -20.87% | +7.06% |
| Aug 27, 2026 | $2.15 | -10.04% | $142.77 | -18.13% | +8.09% |
| Aug 26, 2026 | $2.08 | -12.97% | $149.66 | -14.18% | +1.21% |
Page 1 of 2